Olumide B. Gbolahan, MBBS, MSc

• A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

  • Phase

    I
  • Conditions

    Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma
  • Location

    Winship Cancer Institute

• A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

  • Phase

    I
  • Conditions

    Advanced Solid Tumors
  • Location

    Winship Cancer Institute

• Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

  • Phase

    I/II
  • Conditions

    Locally Advanced Malignant Solid Neoplasm, Locally Advanced Unresectable Cholangiocarcinoma, Locally Advanced Unresectable Gallbladder Carcinoma, Locally Advanced Unresectable Malignant Solid Neoplasm, Metastatic Cholangiocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Malignant Solid Neoplasm, Stage III Gallbladder Cancer AJCC v8, Stage IV Gallbladder Cancer AJCC v8, Unresectable Malignant Solid Neoplasm
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute

• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

  • Phase

    III
  • Conditions

    Biliary Tract Cancer
  • Location

    Emory Saint Joseph's Hospital, Winship Cancer Institute

• Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

  • Phase

    III
  • Conditions

    Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Carcinoma
  • Location

    Emory Saint Joseph's Hospital, Winship Cancer Institute

• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

  • Phase

    III
  • Conditions

    Colorectal Neoplasms
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

• A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

  • Phase

    I/II
  • Conditions

    Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
  • Location

    Winship Cancer Institute

• 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

  • Phase

    II
  • Conditions

    Malignant Digestive System Neoplasm
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute

A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations.

The oncologist

First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors.

Cancer research communications

Alpha radioligand therapy in neuroendocrine neoplasms: current landscape and spotlight on RYZ101.

Future oncology (London, England)

Feasibility and Safety of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Neuroendocrine Tumor in a Patient With Sickle Cell Anemia.

Clinical nuclear medicine

A pilot study of the immune microenvironment of GI neuroendocrine carcinoma.

Endocrine-related cancer

Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.

JAMA network open

Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma.

Current oncology (Toronto, Ont.)

Role of chemoradiation in gallbladder cancer-a single institution retrospective analysis.

Journal of gastrointestinal oncology

Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control.

Journal of cancer research and clinical oncology

Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer?

The Journal of surgical research

Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer.

Cancer medicine

Short- and Long-Term Survival of Metastatic Biliary Tract Cancer in the United States From 2000 to 2018.

Cancer control : journal of the Moffitt Cancer Center

Patient-reported geriatric assessment-based frailty index among older adults with gastrointestinal malignancies.

Journal of the American Geriatrics Society

Differences in Pretreatment Frailty Across Gastrointestinal Cancers in Older Adults: Results From the Cancer and Aging Resilience Evaluation Registry.

JCO oncology practice

Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma?

American journal of surgery

Geriatric Assessment Predictors of 1-Year Mortality in Older Adults With GI Malignancies: A Survival Tree Analysis.

JCO clinical cancer informatics

10/11/2025

Good job

08/20/2025

Dr. Gbaldahan was very kind, attentive and courteous. He answered questions and extended conversations to understand my concerns. He was professional and talked to show understanding and concern.

08/16/2025

Dr. Gbolohan was extraordinarily informative, courteous, and sensitive to my situation.

07/19/2025

This is the most professional, courteous, knowledgeable group of people I have ever worked with. Dr. Gbolohan was top-notch. I would highly recommend him to anybody.

05/03/2025

Fantastic conversation very detailed.

04/26/2025

Great

03/10/2025

Dr. Gbolahan is kind, patient, honest, thoughtful, and thorough.

01/05/2025

Muy bueno

01/04/2025

Dr. Gbolohan was kind, concerned and forthright. It was a pleasure meeting him.

11/03/2024

Dr. Gbolahan is amazing. He listens and is great in sharing information. He is always concerned about me as the pt and my wife who is the primary care taker.

11/02/2024

I loved Dr. Gbolihan!!

09/26/2024

Dr Gbolahan was very caring, knowledgeable, & informative. He clarified everything & gave me options. He mentioned I'd be cared for by another doctor when I return for a follow up. I wish him well.

09/25/2024

Dr. Olu patiently answered all my questions and gave me his perspective on my current condition.

08/15/2024

Good

08/09/2024

Dr Gbolahan did a fantastic job

05/25/2024

Dr. B is awesome explain everything in detail, listen to you, and take the necessary time with you.

05/23/2024

If they are diagnosed with cancer this is the only hospital that I would ever refer them toI.

05/06/2024

Dr. Gbolahan and his entire team are the BEST! He takes time to address all of our concerns. He reviewed my father's charts in detail before he met with us and heard our concerns. Because my father's situation is complex/multiple issues, he and his team looked at his situation from all angles and based his treatment and care from that. Different from past experiences where we felt like a part of a standard assembly line. He takes extra measure to go above and beyond. Because he looked at the WHOLE picture, and not through a single oncologist lens, my father is feeling better than he has in 6 mos. We Thank you!

05/03/2024

Fantastic job

04/25/2024

We really like Dr Gblobohon our only complaint is the excessive delays

03/15/2024

They are very interested in what's going on with any of my wants concerns and needs I if I have any problems or concerns they address them right away.

03/08/2024

Extremely very good..

03/08/2024

Good experience

01/31/2024

We praise God for all staff. Everyone goes that extra mile. My ratings is 100

01/17/2024

The doctor showed compassion and professionalism as we talked. He asked questions to discern my understanding.

12/15/2023

The doctor was a great listener and his compassion was amazing!

12/06/2023

Very professional and seeking to know I understood the situation and decision making needed.

11/02/2023

Dr. Gbolahan was a very good, compassionate listener. He clearly explained my situation and referred me to appropriate doctors for follow up.

11/01/2023

Excellent communication, JOB WELL DONE!

11/01/2023

Always professional , courteous, and caring and making sure I understand.